An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)

An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)

NCT01667380 ·Status: COMPLETED

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

NCT05951192 ·Status: COMPLETED ·Phase: PHASE4

A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)

NCT01194154 ·Status: COMPLETED ·Phase: PHASE2

Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia

NCT00374712 ·Status: TERMINATED

An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)

NCT02547454 ·Status: COMPLETED

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

NCT01121237 ·Status: COMPLETED

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

NCT03519243 ·Status: COMPLETED ·Phase: PHASE2

A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis

NCT02567188 ·Status: COMPLETED

An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis

NCT02238080 ·Status: COMPLETED

Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients

NCT01942460 ·Status: COMPLETED ·Phase: PHASE4

A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis

NCT02490514 ·Status: COMPLETED

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

NCT04239391 ·Status: UNKNOWN ·Phase: PHASE3

Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients

NCT05586867 ·Status: RECRUITING

Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

NCT02909153 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

NCT00317694 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

NCT01324128 ·Status: COMPLETED ·Phase: PHASE3

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

NCT03079869 ·Status: COMPLETED ·Phase: PHASE4

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients

NCT05410275 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

NCT00548691 ·Status: COMPLETED ·Phase: PHASE3

PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease

NCT01581073 ·Status: COMPLETED ·Phase: PHASE3

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00772382 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

NCT01503021 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

NCT01464190 ·Status: COMPLETED ·Phase: PHASE3

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT04456803 ·Status: COMPLETED ·Phase: PHASE3

Study of Phosphate Levels in Patients With Chronic Kidney Disease

NCT00824460 ·Status: COMPLETED ·Phase: PHASE2